TAP
BNTX icon

Tounjian Advisory Partners’s BioNTech BNTX Stock Holding History

Tounjian Advisory Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15K Buy
+45
New +$4.24K ﹤0.01% 470

Other funds holding BNTX

Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
LA
LBP AM Paris, France $10B AUM 43.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Tounjian Advisory Partners's BNTX Position: Q2 2026 in Review

Tounjian Advisory Partners opened a new position in BioNTech (BNTX) in Q2 2026: 45 shares worth $4.15K. The stake represents ﹤0.01% of the portfolio and ranks #470 among its holdings.

119 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Tounjian Advisory Partners held 45 shares of BioNTech worth $4.15K as of Q2 2026.
  • BioNTech was a new Tounjian Advisory Partners position in Q2 2026.
  • BioNTech made up ﹤0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #470 holding.
  • 119 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.